Pharmaceutical

Scout Celebrates Third Consecutive MedTech Breakthrough Award

DALLAS, May 13, 2025 /PRNewswire/ -- Scout, a premier provider of clinical trial services, has received the 2025 Patient Experience…

8 months ago

Segmed Appoints David Gascoigne as CEO in Leadership Transition

Co-Founder Dr. Martin Willemink moves to Chief Scientific Officer role; Dr. Yin Ho joins Board of Directors as part of…

8 months ago

Ubie and CMI Media Group Partner to Modernize DTC Advertising with Highly Personalized Consumer Campaigns in Women’s Health, Hematology

There is a critical need for trustworthy, hyper-personalized information earlier in the diagnosis and treatment journey to empower patients to…

8 months ago

CEFALY to Demonstrate Its Migraine Treatment Device at the American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting

DARIEN, Conn., May 13, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology will be conducting live demonstrations of its clinically…

8 months ago

Hyperion Biosystems and Colorcon Enter into Licensing Agreement to Commercialize Novel On-Dose Authentication Technology for Pharmaceutical and Nutraceutical Industries

This unique on-dose authentication solution combines Hyperion Biosystems' portfolio of physics-based algorithms and AI-enhanced vision systems with Colorcon's custom taggants to…

8 months ago

General Oncology to Participate in Three Upcoming Conferences

BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class treatments for…

8 months ago

Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in neuromuscular…

8 months ago

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

Addresses key challenges for CAR-T therapies Potential to significantly reduce costs and improve clinical efficacy of engineered effector T cells…

8 months ago

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study

Milestone Achieved as Adovate Initiates First-in-Human Study for Novel Asthma Therapy Targeting Underserved, Multi-Billion Dollar MarketGlen Allen, Va., May 13,…

8 months ago